Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Ordinary Shares, no par value
-
Shares outstanding
-
86,723,804
-
Total 13F shares
-
976,001
-
Share change
-
+27,915
-
Total reported value
-
$3,025,475
-
Price per share
-
$3.10
-
Number of holders
-
21
-
Value change
-
+$134,426
-
Number of buys
-
4
-
Number of sells
-
6
Institutional Holders of Alpha Tau Medical Ltd. - Ordinary Shares, no par value (DRTS) as of Q4 2024
As of 31 Dec 2024,
Alpha Tau Medical Ltd. - Ordinary Shares, no par value (DRTS) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
976,001 shares.
The largest 10 holders included
LEVIN CAPITAL STRATEGIES, L.P., HighTower Advisors, LLC, SATOVSKY ASSET MANAGEMENT LLC, NORTHERN TRUST CORP, Private Advisor Group, LLC, MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, Mariner, LLC, GEODE CAPITAL MANAGEMENT, LLC, and Kovitz Investment Group Partners, LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.